Using the EHR to Improve Dyslipidemia Screening and Management in Pediatric T2D

被引：0
|
作者：
Halpin, Kelsee
Boyd, Jennifer
Mcdonough, Ryan
Musick, Tiffany
Cernich, Joseph
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1376-P
引用
收藏
页码：A369 / A369
页数：1
相关论文
共 50 条
  • [1] Expanding Eligibility for Pediatric T2D Clinical Trials: Insights from the Pediatric Diabetes Consortium (PDC) T2D Registry
    Tamborlane, William V.
    Cheng, Peiyao
    Klingensmith, Georgeanna J.
    Gal, Robin L.
    Kollman, Craig
    Vanname, Michelle
    Bacha, Fida
    Willi, Steven M.
    Beck, Roy W.
    [J]. DIABETES, 2017, 66 : A366 - A366
  • [2] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    [J]. DIABETES, 2016, 65 : A306 - A306
  • [3] Therapeutic Inertia: Underdiagnosed and Untreated Hypertension and Dyslipidemia in the Pediatric Diabetes Consortium (PDC) Type 2 Diabetes (T2D) Registry
    Van Name, Michelle
    Tamborlane, William V.
    Cheng, Peiyao
    Gal, Robin L.
    Kollman, Craig
    Beck, Roy W.
    Engle, Courtney
    Hsu, Liana
    Silverstein, Janet
    Willi, Steven M.
    [J]. DIABETES, 2016, 65 : A334 - A334
  • [4] Sleep, the overlooked factor in the management of T2D
    Khodabakhsh, S.
    Searle, A.
    Papadaki, A.
    Johnson, L.
    England, C.
    [J]. JOURNAL OF SLEEP RESEARCH, 2020, 29 : 274 - 275
  • [5] Management of Hypertension and Hyperlipidemia in Youth with T2D
    Beaulieu, Lindsey C.
    Cheng, Peiyao
    Katz, Michelle
    Laffel, Lori M.
    Tamborlane, William V.
    Van Name, Michelle A.
    Bansal, Nidhi
    Kollman, Craig
    Gal, Robin L.
    [J]. DIABETES, 2018, 67
  • [6] NEW TECHNOLOGIES IN TYPE 2 DIABETES (T2D) MANAGEMENT AND FUTURE OPPORTUNITIES TO IMPROVE CLINICAL OUTCOMES
    Edelman, S.
    Kerr, D.
    Khunti, K.
    Vespasiani, G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A46 - A47
  • [7] Why Are Trials of New Drugs in Pediatric T2D Failing?
    Tamborlane, William V.
    Willi, Steven M.
    Bacha, Fida
    Lee, Joyce M.
    Haymond, Morey W.
    Klingensmith, Georgeanna J.
    Bucking-Ham, Bruce A.
    Beck, Roy
    Ruedy, Katrina
    Kollman, Craig
    Connor, Crystal
    [J]. DIABETES, 2014, 63 : A46 - A46
  • [8] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [9] Significant EHR Feature-Driven T2D Inference: Predictive Machine Learning and Networks
    Preo, Nicolo
    Capobianco, Enrico
    [J]. FRONTIERS IN BIG DATA, 2019, 2
  • [10] PUMPS IN T2D
    Lalic, N.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A9 - A9
12345